speb/financial-data huggingface dataset:
Financial ratios for BPE5.DE — annual report dated 2025-12-31
Total revenue: 255858108108.10812
Gross profit: 45309459459.45946
Operating income: 21362162162.162163
Net income: 1750000000
Capital expenditures: 1543243243.2432432
Operating cash flow: 33098648648.648647
Depreciation & amortization: 24083783783.783783
Net tangible assets: 46695945945.945946
Owner earnings: 24290540540.54054
Return on net tangible assets (%): 52.01852119808999
Capex to operating income (%): 7.22419028340081
Buffett classification: The Great
Stock price: 5.6117647058823525
P/E ratio: 49.54637116709244
Shares outstanding: 15450781365
Book value: 100000000000
P/B ratio: 0.8670614954241176
Market cap (USD): 86706149542.41176
Debt to equity: 0.9801216216216218
Current ratio: 1.2631513632245814
Quick ratio: 0.9839416239560195
Effective tax rate (%): 83.28169377743352
Interest coverage ratio: 3.0826833073322932
COGS to revenue (%): 82.29117701428684
SG&A to revenue (%): 9.23970739694193
Free cash flow (dilution-adjusted): 13777027027.027027
Buyback yield (%): 6.9916173122148555
Retained earnings: 18879729729.72973
Inventory turnover: 6.925018889728433
Receivables turnover: 7.2781963558084115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.986056732930863
FCF margin (%): 5.384635698629413
Revenue growth (%): 8.19382429182361
Rule of 40 score: 13.578459990453023
Financial ratios for BPE5.DE — quarterly report dated 2025-12-31
Total revenue: 64031081081.081085
Gross profit: 10375675675.675676
Operating income: 4522972972.972973
Net income: -4222972972.972973
Capital expenditures: 672972972.972973
Operating cash flow: 10272972972.972973
Depreciation & amortization: 6116216216.216216
Net tangible assets: 46695945945.945946
Owner earnings: 1220270270.2702703
Capex to operating income (%): 14.878996115924709
Buffett classification: The Great
Stock price: 5.6117647058823525
P/E ratio: 50.00335482805165
Shares outstanding: 15450781365
Book value: 100000000000
P/B ratio: 0.8670614954241176
Market cap (USD): 86706149542.41176
Debt to equity: 0.9801216216216218
Current ratio: 1.2631513632245814
Quick ratio: 0.9839416239560195
Interest coverage ratio: 2.55301296720061
COGS to revenue (%): 83.79587615811576
SG&A to revenue (%): 9.64480931979824
Free cash flow (dilution-adjusted): 5327027027.027027
Buyback yield (%): 1.287355305369922
Retained earnings: 18879729729.72973
Inventory turnover: 1.7647450997822125
Receivables turnover: 1.8214423002998386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6908737275505819
FCF margin (%): 8.319439461410209
Revenue growth (%): -2.141676992978104
Rule of 40 score: 6.177762468432105
Financial ratios for BRR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -10423
Buffett classification: The Gruesome
Stock price: 10.62
Shares outstanding: 90573524
Book value: -10423
Market cap (USD): 961890824.8799999
Debt to equity: 0
Current ratio: 0.8962090357786563
Quick ratio: 0.8962090357786563
Buyback yield (%): 0
Retained earnings: -10423
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRR — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -319048
Net income: -319048
Capital expenditures: 0
Operating cash flow: -108674
Net tangible assets: -329471
Owner earnings: -319048
Buffett classification: The Gruesome
Stock price: 10.12
Shares outstanding: 90573524
Book value: -329471
Market cap (USD): 916604062.8799999
Debt to equity: -0.6346446272964844
Quick ratio: 0
Free cash flow (dilution-adjusted): -108674
Buyback yield (%): 0
Retained earnings: -329471
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRR — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: -21614641
Buffett classification: The Gruesome
Stock price: 3.53
Shares outstanding: 90573524
Book value: 420176675
P/B ratio: 0.7609288157654158
Market cap (USD): 319724539.71999997
Debt to equity: 0.5151424647738954
Current ratio: 87.21021591522738
Quick ratio: 87.21021591522738
Buyback yield (%): 0
Retained earnings: -28975504
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRR — quarterly report dated 2025-12-31
Total revenue: 436.21
Operating income: -7668330
Net income: -28656456
Capital expenditures: 0
Operating cash flow: -7383140
Owner earnings: -28656456
Buffett classification: The Gruesome
Stock price: 3.53
Shares outstanding: 90573524
Market cap (USD): 319724539.71999997
COGS to revenue (%): 0
SG&A to revenue (%): 1777430.595355448
Free cash flow (dilution-adjusted): -7467722
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): -1711955.7094060201
Rule of 40 score: -1711955.7094060201
Financial ratios for BRW — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.99
Shares outstanding: 50895000
Market cap (USD): 253966050
Buyback yield (%): 70.2345254414911
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRW — annual report dated 2022-10-31
Total revenue: -6115217
Net income: -7254055
Capital expenditures: 0
Operating cash flow: -74864361
Net tangible assets: 367459211
Owner earnings: -7254055
Return on net tangible assets (%): -1.97411162459607
Buffett classification: The Gruesome
Stock price: 4.71
Shares outstanding: 50895000
Book value: 367459211
P/B ratio: 0.652359344449798
Market cap (USD): 239715450
Debt to equity: 0.4776040299068731
Free cash flow (dilution-adjusted): -74864361
Buyback yield (%): 0
Retained earnings: -185552593
Receivables turnover: -0.37719083661721353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRW — annual report dated 2023-10-31
Total revenue: 34247553
Net income: 30596196
Capital expenditures: 0
Operating cash flow: 165869907
Net tangible assets: 353867263
Owner earnings: 30596196
Return on net tangible assets (%): 8.646235241037258
Buffett classification: The Gruesome
Stock price: 5.05
P/E ratio: 8.400382518140491
Shares outstanding: 50895000
Book value: 353867263
P/B ratio: 0.7263168336653961
Market cap (USD): 257019750
Debt to equity: 0.16806167232259628
COGS to revenue (%): 0
SG&A to revenue (%): 4.129757825325505
Free cash flow (dilution-adjusted): 165869907
Buyback yield (%): 0
Retained earnings: -172516811
Receivables turnover: 0.10514885167407705
Capitalized R&D asset: 0
FCF margin (%): 484.3263020864586
Rule of 40 score: 484.3263020864586
Financial ratios for BRW — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 343151069
Buffett classification: The Gruesome
Stock price: 5.96
Shares outstanding: 50895000
Book value: 343151069
P/B ratio: 0.883966938771215
Market cap (USD): 303334200
Debt to equity: 0.25061848197243997
Buyback yield (%): 0
Retained earnings: -189534230
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRW — annual report dated 2024-10-31
Total revenue: 40585009
Net income: 37524585
Capital expenditures: 0
Operating cash flow: 36366343
Net tangible assets: 343151069
Owner earnings: 37524585
Return on net tangible assets (%): 10.935295964355571
Buffett classification: The Gruesome
Stock price: 5.96
P/E ratio: 8.083612383721233
Shares outstanding: 50895000
Book value: 343151069
P/B ratio: 0.883966938771215
Market cap (USD): 303334200
Debt to equity: 0.25061848197243997
COGS to revenue (%): 0
SG&A to revenue (%): 4.49486410117588
Free cash flow (dilution-adjusted): 36366343
Buyback yield (%): 0
Retained earnings: -189534230
Receivables turnover: 0.42000216805309093
Capitalized R&D asset: 0
FCF margin (%): 89.60535896394651
Revenue growth (%): 18.504843251136805
Rule of 40 score: 108.11020221508332
Financial ratios for BRW — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 344306121
Buffett classification: The Gruesome
Stock price: 6.52
Shares outstanding: 50895000
Book value: 344306121
P/B ratio: 0.9637801356427235
Market cap (USD): 331835400
Debt to equity: 0.13069764739965223
Buyback yield (%): 0
Retained earnings: -188379178
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BXT.DE — annual report dated 2021-12-31
Gross profit: 157069.29133858267
Capital expenditures: 356178.7401574803
Buffett classification: The Gruesome
Stock price: 0.875
Shares outstanding: 129994546
Market cap (USD): 113745227.75
Buyback yield (%): 0
Inventory turnover: 0.11820735596959372
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BXT.DE — annual report dated 2022-12-31
Total revenue: 218707.35294117645
Gross profit: 143834.5588235294
Operating income: -4444800
Net income: -9100052.205882352
Capital expenditures: 2836.7647058823527
Operating cash flow: -4580672.794117646
Depreciation & amortization: 158530.88235294117
Net tangible assets: -3035593.3823529407
Owner earnings: -8944358.088235293
Buffett classification: The Gruesome
Stock price: 0.4255319148936171
Shares outstanding: 129994546
Book value: -3035584.5588235296
Market cap (USD): 55316828.08510639
Debt to equity: -1.058767390232766
Current ratio: 0.3425826372437778
Quick ratio: 0.3425826372437778
Interest coverage ratio: -5.29067831767554
COGS to revenue (%): 34.23423726306305
R&D to revenue (%): 709.5793465616827
SG&A to revenue (%): 1152.1610935913554
Free cash flow (dilution-adjusted): -4667204.411764706
Buyback yield (%): 0
Retained earnings: -40843231.61764706
Receivables turnover: 0.648421575829978
Capitalized R&D asset: 1551902.2058823528
ROCI (R&D-adjusted, %): -271.8825256355242
FCF margin (%): -2133.9951990640193
Rule of 40 score: -2133.9951990640193
Financial ratios for BXT.DE — annual report dated 2023-12-31
Total revenue: 282005.30303030304
Gross profit: 282005.30303030304
Operating income: -4838815.909090909
Net income: -5850702.2727272725
Capital expenditures: 76393.93939393939
Operating cash flow: -3914821.9696969697
Depreciation & amortization: 148305.303030303
Net tangible assets: -4002018.1818181816
Owner earnings: -5778790.909090909
Buffett classification: The Gruesome
Stock price: 0.4111111111111111
Shares outstanding: 129994546
Book value: -4002016.6666666665
Market cap (USD): 53442202.244444445
Debt to equity: -0.9264562071167908
Current ratio: 0.10977144428300793
Quick ratio: 0.10977144428300793
Interest coverage ratio: -6.126575709848774
COGS to revenue (%): 0
R&D to revenue (%): 685.9708741776293
SG&A to revenue (%): 944.9397846053829
Free cash flow (dilution-adjusted): -4532914.393939394
Buyback yield (%): 0
Retained earnings: -45400323.484848484
Receivables turnover: 1.3173947048976689
Capitalized R&D asset: 2974248.720365419
Rosenberg metric: 0.08903315149823825
FCF margin (%): -1607.3862247378756
Revenue growth (%): 28.94184819938414
Rule of 40 score: -1578.4443765384915
Financial ratios for BXT.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 17031.11111111111
Buffett classification: The Gruesome
Stock price: 0.2111111111111111
Shares outstanding: 129994546
Market cap (USD): 27443293.044444446
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BXT.DE — quarterly report dated 2024-12-31
Total revenue: 3193.006993006993
Operating income: -758963.6363636364
Net income: -907278.3216783217
Capital expenditures: 0
Operating cash flow: -758462.9370629371
Depreciation & amortization: 15932.867132867133
Net tangible assets: -5497525.874125875
Owner earnings: -891345.4545454546
Buffett classification: The Gruesome
Stock price: 0.28125000000000006
Shares outstanding: 129994546
Book value: -5497524.475524476
Market cap (USD): 36560966.06250001
Debt to equity: -0.5444046016897625
Current ratio: 0.023800194220239473
Quick ratio: 0.023800194220239473
Interest coverage ratio: -4.088812369083319
COGS to revenue (%): 0
R&D to revenue (%): 5029.697766097241
SG&A to revenue (%): 16797.262374069207
Free cash flow (dilution-adjusted): -834846.1538461539
Buyback yield (%): 0
Retained earnings: -45236588.11188811
Receivables turnover: 0.07534777801613889
Capitalized R&D asset: 160598.6013986014
FCF margin (%): -26146.0797196671
Rule of 40 score: -26146.0797196671
Financial ratios for BXT.DE — annual report dated 2024-12-31
Total revenue: 18870.629370629373
Operating income: -3193979.020979021
Net income: -3714339.160839161
Capital expenditures: 39308.39160839161
Operating cash flow: -2121760.839160839
Depreciation & amortization: 64167.13286713287
Net tangible assets: -5497525.874125875
Owner earnings: -3689480.4195804195
Buffett classification: The Gruesome
Stock price: 0.28125000000000006
Shares outstanding: 129994546
Book value: -5497524.475524476
Market cap (USD): 36560966.06250001
Debt to equity: -0.5444046016897625
Current ratio: 0.023800194220239473
Quick ratio: 0.023800194220239473
Interest coverage ratio: -4.636247548591684
COGS to revenue (%): 0
R&D to revenue (%): 5301.504539559014
SG&A to revenue (%): 10363.553826199739
Free cash flow (dilution-adjusted): -2503436.3636363638
Buyback yield (%): 0
Retained earnings: -45236588.11188811
Receivables turnover: 0.44530437796003236
Capitalized R&D asset: 2808652.7430926915
FCF margin (%): -13266.310913470446
Revenue growth (%): -93.30841329299342
Rule of 40 score: -13359.619326763439
Financial ratios for BXT.DE — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1290318.8811188813
Net income: -1380775.5244755244
Capital expenditures: 58183.21678321678
Operating cash flow: -919954.5454545455
Depreciation & amortization: -4161.538461538462
Net tangible assets: -5287169.93006993
Owner earnings: -1443120.2797202796
Buffett classification: The Gruesome
Stock price: 0.4021739130434782
Shares outstanding: 129994546
Book value: -5287168.531468532
Market cap (USD): 52280415.23913043
Debt to equity: -0.8834883398268217
Current ratio: 0.15330556183230382
Quick ratio: 0.15330556183230382
Interest coverage ratio: -7.268972581153483
Free cash flow (dilution-adjusted): -1646424.4755244758
Buyback yield (%): 0
Retained earnings: -46617363.63636364
Receivables turnover: 0
Capitalized R&D asset: 217214.34965034967
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for BXT.DE — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -825223.3576642335
Net income: -949124.0875912408
Capital expenditures: 1302.1897810218977
Operating cash flow: -553370.802919708
Depreciation & amortization: 4975.9124087591235
Net tangible assets: -6138875.182481752
Owner earnings: -945450.3649635036
Buffett classification: The Gruesome
Stock price: 0.4117647058823529
Shares outstanding: 129994546
Book value: -6138873.722627737
Market cap (USD): 53527166
Debt to equity: -0.8398715996431501
Current ratio: 0.060657402422449616
Quick ratio: 0.060657402422449616
Interest coverage ratio: -2.945774891932807
Free cash flow (dilution-adjusted): -740789.7810218977
Buyback yield (%): 0
Retained earnings: -49545349.63503649
Receivables turnover: 0
Capitalized R&D asset: 356943.5500484917
Rule of 40 score: 0
Financial ratios for BXT.DE — quarterly report dated 2025-09-30
Total revenue: 8097.841726618705
Operating income: -931133.0935251799
Net income: -1153782.7338129496
Capital expenditures: 34996.402877697845
Operating cash flow: -1457884.892086331
Depreciation & amortization: 3990.647482014389
Net tangible assets: -5978738.848920864
Owner earnings: -1184788.489208633
Buffett classification: The Gruesome
Stock price: 0.6352941176470589
Shares outstanding: 129994546
Book value: -5978737.410071943
Market cap (USD): 82584770.4
Debt to equity: -1.002623926877562
Current ratio: 0.22318771226746725
Quick ratio: 0.22318771226746725
Interest coverage ratio: -3.4002600882723835
COGS to revenue (%): 0
R&D to revenue (%): 1223.3742004264393
SG&A to revenue (%): 9672.414712153519
Free cash flow (dilution-adjusted): -1556864.748201439
Buyback yield (%): 0
Retained earnings: -49986249.64028777
Receivables turnover: 0.08540406837788417
Capitalized R&D asset: 289677.714447869
FCF margin (%): -19225.675195451317
Rule of 40 score: -19225.675195451317
Financial ratios for BXT.DE — quarterly report dated 2025-12-31
Total revenue: -8216.058394160584
Operating income: -1300541.605839416
Net income: -1567094.1605839415
Capital expenditures: 2774.4525547445255
Operating cash flow: -799796.3503649634
Depreciation & amortization: 3277.3722627737225
Net tangible assets: -6836220.437956204
Owner earnings: -1566591.2408759121
Buffett classification: The Gruesome
Stock price: 0.5176470588235295
Shares outstanding: 129994546
Book value: -6836218.9781021895
Market cap (USD): 67291294.4
Debt to equity: -0.6349736589782631
Current ratio: 0.054065900813546695
Quick ratio: 0.054065900813546695
Interest coverage ratio: -4.221117170731245
Free cash flow (dilution-adjusted): -1158450.3649635036
Buyback yield (%): 0
Retained earnings: -52092002.18978102
Receivables turnover: -0.14097313544993426
Capitalized R&D asset: 281494.0682140419
Revenue growth (%): -201.45985401459856
Rule of 40 score: -201.45985401459856
Financial ratios for BXT.DE — annual report dated 2025-12-31
Total revenue: 0
Operating income: -4417320.437956204
Net income: -5128091.970802919
Capital expenditures: 100315.32846715327
Operating cash flow: -3792579.5620437954
Depreciation & amortization: 7958.394160583941
Net tangible assets: -6836220.437956204
Owner earnings: -5220448.905109488
Buffett classification: The Gruesome
Stock price: 0.5176470588235295
Shares outstanding: 129994546
Book value: -6836218.9781021895
Market cap (USD): 67291294.4
Debt to equity: -0.6349736589782631
Current ratio: 0.054065900813546695
Quick ratio: 0.054065900813546695
Interest coverage ratio: -4.201507111709414
Free cash flow (dilution-adjusted): -5197363.503649635
Buyback yield (%): 0
Retained earnings: -52092002.18978102
Receivables turnover: 0
Capitalized R&D asset: 1893147.4442601195
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CALX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 79.97
Shares outstanding: 62963989
Market cap (USD): 5035230200.33
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CALX — annual report dated 2022-12-31
Total revenue: 867827000
Gross profit: 435428000
Operating income: 52610000
Net income: 41010000
Capital expenditures: 14067000
Operating cash flow: 27183000
Depreciation & amortization: 14315000
Net tangible assets: 563392000
Owner earnings: 41258000
Return on net tangible assets (%): 7.323142678632284
Capex to operating income (%): 26.73826268770196
Buffett classification: The Good
Stock price: 68.43
P/E ratio: 105.06280827286028
Shares outstanding: 62963989
Book value: 679567000
P/B ratio: 6.340251612085343
Market cap (USD): 4308625767.27
Debt to equity: 0.01823366938064974
Current ratio: 3.3089310974356496
Quick ratio: 2.407237247766319
Effective tax rate (%): 24.11457755079383
COGS to revenue (%): 49.82548365054325
R&D to revenue (%): 15.209713456714299
SG&A to revenue (%): 28.902534721782107
Free cash flow (dilution-adjusted): -31710000
Buyback yield (%): 0
Retained earnings: -389704000
Inventory turnover: 2.8988938053097346
Receivables turnover: 9.2514924736685
Capitalized R&D asset: 131994000
ROCI (R&D-adjusted, %): 16.514545922220513
FCF margin (%): -3.6539540714912078
Rule of 40 score: -3.6539540714912078
Financial ratios for CALX — annual report dated 2023-12-31
Total revenue: 1039593000
Gross profit: 518316000
Operating income: 25585000
Net income: 29325000
Capital expenditures: 17855000
Operating cash flow: 56251000
Depreciation & amortization: 16631000
Net tangible assets: 602807000
Owner earnings: 28101000
Return on net tangible assets (%): 4.661691055346073
Capex to operating income (%): 69.78698456126637
Buffett classification: The Good
Stock price: 43.69
P/E ratio: 93.80721839420289
Shares outstanding: 62963989
Book value: 718982000
P/B ratio: 3.8260995121018326
Market cap (USD): 2750896679.41
Debt to equity: 0.01608246103518586
Current ratio: 3.1866852836784942
Quick ratio: 2.4779686850491895
Effective tax rate (%): 15.628506487901717
COGS to revenue (%): 50.142411501424114
R&D to revenue (%): 17.100153617810047
SG&A to revenue (%): 30.296375600836097
Free cash flow (dilution-adjusted): -24375000
Buyback yield (%): 3.140685022693402
Retained earnings: -360379000
Inventory turnover: 3.9198180245892393
Receivables turnover: 8.248970458711229
Capitalized R&D asset: 266207980
ROCI (R&D-adjusted, %): 9.809743983533965
Rosenberg metric: 0.6279679379365729
FCF margin (%): -2.344667576638165
Revenue growth (%): 19.792654526766277
Rule of 40 score: 17.44798695012811
Financial ratios for CALX — annual report dated 2024-12-31
Total revenue: 831518000
Gross profit: 453594000
Operating income: -43034000
Net income: -29747000
Capital expenditures: 18054000
Operating cash flow: 68400000
Depreciation & amortization: 19550000
Net tangible assets: 664765000
Owner earnings: -28251000
Return on net tangible assets (%): -4.249772475987755
Buffett classification: The Gruesome
Stock price: 34.87
Shares outstanding: 62963989
Book value: 780940000
P/B ratio: 2.811425072899326
Market cap (USD): 2195554296.43
Debt to equity: 0.010273516531359644
Current ratio: 4.458758759522048
Quick ratio: 3.6754382620498234
COGS to revenue (%): 45.44988803609783
R&D to revenue (%): 21.631522107759544
SG&A to revenue (%): 38.093943847276904
Free cash flow (dilution-adjusted): -20415000
Buyback yield (%): 0.4871207247021953
Retained earnings: -390126000
Inventory turnover: 3.678915961723792
Receivables turnover: 10.482949029891202
Capitalized R&D asset: 342535260
ROCI (R&D-adjusted, %): -2.2922511395771497
Rosenberg metric: -0.3640730823751772
FCF margin (%): -2.455148295045928
Revenue growth (%): -20.015044349086615
Rule of 40 score: -22.470192644132542
Financial ratios for CALX — quarterly report dated 2025-03-31
Total revenue: 220242000
Gross profit: 122708000
Operating income: -6081000
Net income: -4787000
Capital expenditures: 4310000
Operating cash flow: 17212000
Depreciation & amortization: 4271000
Net tangible assets: 650991000
Owner earnings: -4826000
Return on net tangible assets (%): -0.741331293366575
Buffett classification: The Gruesome
Stock price: 35.44
Shares outstanding: 62963989
Book value: 767166000
P/B ratio: 2.9086843918526104
Market cap (USD): 2231443770.16
Debt to equity: 0.009175328416535665
Current ratio: 4.57565296684687
Quick ratio: 3.7546814954731973
COGS to revenue (%): 44.28492294839313
R&D to revenue (%): 19.968943253330426
SG&A to revenue (%): 38.50718754824239
Free cash flow (dilution-adjusted): -6843000
Buyback yield (%): 1.7913962491259088
Retained earnings: -394913000
Inventory turnover: 0.9672633510189914
Receivables turnover: 2.9166876349141186
Capitalized R&D asset: 43980000
ROCI (R&D-adjusted, %): 2.772240613163938
FCF margin (%): -3.1070368049690793
Rule of 40 score: -3.1070368049690793
Financial ratios for CALX — quarterly report dated 2025-06-30
Total revenue: 241882000
Gross profit: 136295000
Operating income: 391000
Net income: -199000
Capital expenditures: 3735000
Operating cash flow: 39381000
Depreciation & amortization: 4342000
Net tangible assets: 656497000
Owner earnings: 408000
Capex to operating income (%): 955.2429667519182
Buffett classification: The Gruesome
Stock price: 53.19
Shares outstanding: 62963989
Book value: 772672000
P/B ratio: 4.334380662053238
Market cap (USD): 3349054574.91
Debt to equity: 0.007726435020293216
Current ratio: 4.547920609501626
Quick ratio: 3.654033419064719
Effective tax rate (%): 105.80682812955938
COGS to revenue (%): 43.652276729975775
R&D to revenue (%): 18.92947800993873
SG&A to revenue (%): 37.25659619153141
Free cash flow (dilution-adjusted): 10034000
Buyback yield (%): 1.0019842689754253
Retained earnings: -395112000
Inventory turnover: 0.9553482564557283
Receivables turnover: 3.834770752742723
Capitalized R&D asset: 75253600
ROCI (R&D-adjusted, %): 1.8620090438802916
Rosenberg metric: 0.30893587994542976
FCF margin (%): 4.148303718342001
Revenue growth (%): 9.825555525285822
Rule of 40 score: 13.973859243627823
Financial ratios for CALX — quarterly report dated 2025-09-30
Total revenue: 265437000
Gross profit: 152010000
Operating income: 17405000
Net income: 15658000
Capital expenditures: 5625000
Operating cash flow: 32314000
Depreciation & amortization: 4697000
Net tangible assets: 706331000
Owner earnings: 14730000
Return on net tangible assets (%): 2.085424538920138
Capex to operating income (%): 32.318299339270325
Buffett classification: The Good
Stock price: 61.37
P/E ratio: 61.69529960611189
Shares outstanding: 62963989
Book value: 822506000
P/B ratio: 4.697959656136247
Market cap (USD): 3864100004.93
Debt to equity: 0.013759170145871276
Current ratio: 5.018851770615047
Quick ratio: 4.138387651764092
Effective tax rate (%): 22.99596734533294
COGS to revenue (%): 42.73217373614078
R&D to revenue (%): 17.72737033646402
SG&A to revenue (%): 32.983344447081606
Free cash flow (dilution-adjusted): 6070000
Buyback yield (%): 0.09003390169926577
Retained earnings: -379454000
Inventory turnover: 1.0504347987145888
Receivables turnover: 3.0347796261361686
Capitalized R&D asset: 92245690
ROCI (R&D-adjusted, %): 1.992937738751134
Rosenberg metric: 0.34321969117871887
FCF margin (%): 2.2867949833670513
Revenue growth (%): 9.738219462382485
Rule of 40 score: 12.025014445749537
Financial ratios for CALX — annual report dated 2025-12-31
Total revenue: 1000010000
Gross profit: 568316000
Operating income: 20990000
Net income: 17884000
Capital expenditures: 19435000
Operating cash flow: 134953000
Depreciation & amortization: 17710000
Net tangible assets: 743044000
Owner earnings: 16159000
Return on net tangible assets (%): 2.17470297855847
Capex to operating income (%): 92.59171033825632
Buffett classification: The Gruesome
Stock price: 52.93
P/E ratio: 186.35003006989487
Shares outstanding: 62963989
Book value: 859219000
P/B ratio: 3.8787363149208756
Market cap (USD): 3332683937.77
Debt to equity: 0.0181478761526456
Current ratio: 4.236211163383318
Quick ratio: 3.4169852004312458
Effective tax rate (%): 47.658627955982205
COGS to revenue (%): 43.1689683103169
R&D to revenue (%): 19.035409645903542
SG&A to revenue (%): 35.696643033569664
Free cash flow (dilution-adjusted): 27589000
Buyback yield (%): 2.8094473327899996
Retained earnings: -372242000
Inventory turnover: 3.2279324345543867
Receivables turnover: 10.06380387855123
Capitalized R&D asset: 369533660
ROCI (R&D-adjusted, %): 2.2675384492848503
Rosenberg metric: 0.6378050814477122
FCF margin (%): 2.7588724112758873
Revenue growth (%): 20.2631813141748
Rule of 40 score: 23.02205372545069
Financial ratios for CALX — quarterly report dated 2025-12-31
Total revenue: 272449000
Gross profit: 157303000
Operating income: 9275000
Net income: 7212000
Capital expenditures: 5765000
Operating cash flow: 46046000
Depreciation & amortization: 4400000
Net tangible assets: 743044000
Owner earnings: 5847000
Return on net tangible assets (%): 0.78689821867884
Capex to operating income (%): 62.15633423180593
Buffett classification: The Good
Stock price: 52.93
P/E ratio: 186.35003006989487
Shares outstanding: 62963989
Book value: 859219000
P/B ratio: 3.8787363149208756
Market cap (USD): 3332683937.77
Debt to equity: 0.0181478761526456
Current ratio: 4.236211163383318
Quick ratio: 3.4169852004312458
Effective tax rate (%): 46.167052325147424
COGS to revenue (%): 42.26332267690467
R&D to revenue (%): 19.649182048750408
SG&A to revenue (%): 34.68318841324432
Free cash flow (dilution-adjusted): 18328000
Buyback yield (%): 0.49869715551607174
Retained earnings: -372242000
Inventory turnover: 0.8609883577469212
Receivables turnover: 2.7418458844485594
Capitalized R&D asset: 100170560
ROCI (R&D-adjusted, %): 1.4081145814890987
Rosenberg metric: 0.11248538943789183
FCF margin (%): 6.727130582237409
Revenue growth (%): 2.6416814536029265
Rule of 40 score: 9.368812035840335
Financial ratios for CBLT.V — annual report dated 2022-05-31
Total revenue: 0
Operating income: -387450.3937007874
Net income: 459018.11023622047
Capital expenditures: 0
Operating cash flow: -166081.88976377953
Net tangible assets: 542267.7165354331
Owner earnings: 459018.11023622047
Return on net tangible assets (%): 84.64787709821687
Buffett classification: The Gruesome
Stock price: 0.03937007874015748
P/E ratio: 6.619493595538577
Shares outstanding: 77177073
Book value: 542267.7165354332
P/B ratio: 5.60326080327583
Market cap (USD): 3038467.4409448816
Debt to equity: 0.16716617296857755
Current ratio: 1.8458789990652935
Quick ratio: 1.8458789990652935
Effective tax rate (%): -1.6901462502442157
Free cash flow (dilution-adjusted): -284948.031496063
Buyback yield (%): 0
Retained earnings: -3325573.228346457
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -71.45002032874483
Rule of 40 score: 0
Financial ratios for CBLT.V — annual report dated 2023-05-31
Total revenue: 0
Operating income: -327316.1764705882
Net income: -671083.0882352941
Capital expenditures: 0
Operating cash flow: -218546.32352941175
Net tangible assets: -135820.5882352941
Owner earnings: -671083.0882352941
Buffett classification: The Gruesome
Stock price: 0.029411764705882353
Shares outstanding: 77177073
Book value: -135820.5882352941
Market cap (USD): 2269913.911764706
Debt to equity: -0.31561424023906975
Current ratio: 0.7422626182007945
Quick ratio: 0.7422626182007945
Free cash flow (dilution-adjusted): -218546.32352941175
Buyback yield (%): 0
Retained earnings: -3709221.3235294116
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBLT.V — annual report dated 2024-05-31
Total revenue: 0
Operating income: -57897.8102189781
Net income: 28305.839416058392
Capital expenditures: 131386.8613138686
Operating cash flow: -231102.18978102188
Net tangible assets: -43285.40145985401
Owner earnings: -103081.02189781022
Buffett classification: The Gruesome
Stock price: 0.0218978102189781
P/E ratio: 59.705309316898315
Shares outstanding: 77177073
Book value: -43285.40145985401
Market cap (USD): 1690008.8978102189
Debt to equity: 0
Current ratio: 0.793271141416888
Quick ratio: 0.793271141416888
Effective tax rate (%): -8.609438453998038
Free cash flow (dilution-adjusted): -267612.40875912405
Buyback yield (%): 0
Retained earnings: -3627535.03649635
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBLT.V — quarterly report dated 2024-11-30
Total revenue: 0
Operating income: -52580.71428571429
Net income: -56049.28571428572
Capital expenditures: 0
Operating cash flow: -61520.71428571429
Net tangible assets: -127147.85714285714
Owner earnings: -56049.28571428572
Buffett classification: The Gruesome
Stock price: 0.02142857142857143
Shares outstanding: 77177073
Book value: -127147.85714285714
Market cap (USD): 1653794.4214285715
Debt to equity: 0
Current ratio: 0.3177717307987123
Quick ratio: 0.3177717307987123
Free cash flow (dilution-adjusted): -61520.71428571429
Buyback yield (%): 0
Retained earnings: -3634592.142857143
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBLT.V — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -38797.91666666667
Net income: -43158.333333333336
Capital expenditures: 0
Operating cash flow: -5476.388888888889
Net tangible assets: -166817.36111111112
Owner earnings: -43158.333333333336
Buffett classification: The Gruesome
Stock price: 0.006944444444444445
Shares outstanding: 77177073
Book value: -166817.36111111112
Market cap (USD): 535951.8958333334
Debt to equity: 0
Current ratio: 0.2400216398172638
Quick ratio: 0.2400216398172638
Free cash flow (dilution-adjusted): -5476.388888888889
Buyback yield (%): 0
Retained earnings: -3576833.3333333335
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBLT.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -48851.824817518245
Net income: -36730.656934306564
Capital expenditures: 0
Operating cash flow: -113.86861313868613
Net tangible assets: -258376.6423357664
Owner earnings: -36730.656934306564
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 77177073
Book value: -258376.6423357664
Market cap (USD): 2253345.197080292
Debt to equity: -0.07062625714737722
Current ratio: 0.23182291666666668
Quick ratio: 0.23182291666666668
Free cash flow (dilution-adjusted): -113.86861313868613
Buyback yield (%): 0
Retained earnings: -3803626.2773722624
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBLT.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: 10373.57142857143
Net income: 16950.714285714286
Capital expenditures: 0
Operating cash flow: 8078.571428571429
Net tangible assets: -235888.57142857145
Owner earnings: 16950.714285714286
Return on net tangible assets (%): -7.185898911108151
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.03571428571428572
P/E ratio: 40.65203373224896
Shares outstanding: 77177073
Book value: -235888.57142857142
Market cap (USD): 2756324.035714286
Debt to equity: -0.0757016024515207
Current ratio: 0.2514953366348976
Quick ratio: 0.2514953366348976
Free cash flow (dilution-adjusted): 8078.571428571429
Buyback yield (%): 0
Retained earnings: -3705168.571428572
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.65
Shares outstanding: 800189310
Market cap (USD): 61334510611.50001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CL — annual report dated 2022-12-31
Total revenue: 17967000000
Gross profit: 10248000000
Operating income: 3617000000
Net income: 1967000000
Capital expenditures: 47000000
Operating cash flow: 2556000000
Depreciation & amortization: 545000000
Net tangible assets: -4871000000
Owner earnings: 2465000000
Return on net tangible assets (%): -50.60562512831041
Capex to operating income (%): 1.299419408349461
Buffett classification: The Great
Stock price: 72.48
P/E ratio: 29.48536918596848
Shares outstanding: 800189310
Book value: 806000000
P/B ratio: 71.95747045756823
Market cap (USD): 57997721188.8
Debt to equity: 11.502481389578163
Current ratio: 1.276973026973027
Quick ratio: 0.758991008991009
Effective tax rate (%): 26.052631578947366
Interest coverage ratio: 21.65868263473054
COGS to revenue (%): 42.96209717815996
SG&A to revenue (%): 36.539210775310295
Free cash flow (dilution-adjusted): 1735000000
Buyback yield (%): 2.255261022656506
Retained earnings: 24573000000
Inventory turnover: 3.7217936354869816
Receivables turnover: 11.946143617021276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.84335294619255
FCF margin (%): 9.65659264206601
Rule of 40 score: 9.65659264206601
Financial ratios for CL — annual report dated 2023-12-31
Total revenue: 19457000000
Gross profit: 11326000000
Operating income: 4085000000
Net income: 2455000000
Capital expenditures: 0
Operating cash flow: 3745000000
Depreciation & amortization: 567000000
Net tangible assets: -4688000000
Owner earnings: 3022000000
Return on net tangible assets (%): -64.46245733788396
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 75.22
P/E ratio: 24.51740932716904
Shares outstanding: 800189310
Book value: 957000000
P/B ratio: 62.89471253730407
Market cap (USD): 60190239898.2
Debt to equity: 9.471264367816092
Current ratio: 1.1134781691626239
Quick ratio: 0.7055473528791394
Effective tax rate (%): 27.62382075471698
Interest coverage ratio: 14.233449477351916
COGS to revenue (%): 41.789587295060905
SG&A to revenue (%): 36.75283959500437
Free cash flow (dilution-adjusted): 2918000000
Buyback yield (%): 1.8740579899794236
Retained earnings: 25289000000
Inventory turnover: 4.2042399172699065
Receivables turnover: 12.26796973518285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.05835907998627
FCF margin (%): 14.997173253841806
Revenue growth (%): 8.292981577336228
Rule of 40 score: 23.290154831178036
Financial ratios for CL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 99.62
Shares outstanding: 800189310
Market cap (USD): 79714859062.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CL — annual report dated 2024-12-31
Total revenue: 20101000000
Gross profit: 12161000000
Operating income: 4330000000
Net income: 3049000000
Capital expenditures: 0
Operating cash flow: 4107000000
Depreciation & amortization: 605000000
Net tangible assets: -4816000000
Owner earnings: 3654000000
Return on net tangible assets (%): -75.87209302325581
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 87.68
P/E ratio: 23.011019580452608
Shares outstanding: 800189310
Book value: 544000000
P/B ratio: 128.9716887882353
Market cap (USD): 70160598700.8
Debt to equity: 15.647058823529411
Current ratio: 0.9232505643340858
Quick ratio: 0.5782253863517972
Effective tax rate (%): 22.927199191102122
Interest coverage ratio: 14.82876712328767
COGS to revenue (%): 39.500522362071536
SG&A to revenue (%): 38.450823342122284
Free cash flow (dilution-adjusted): 3411000000
Buyback yield (%): 2.4785991456771463
Retained earnings: 26145000000
Inventory turnover: 3.995973829894313
Receivables turnover: 13.215647600262985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.09196072713134
FCF margin (%): 16.96930500970101
Revenue growth (%): 3.3098627743228657
Rule of 40 score: 20.279167784023876
Financial ratios for CL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 87.68
Shares outstanding: 800189310
Market cap (USD): 70160598700.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CL — quarterly report dated 2025-03-31
Total revenue: 4911000000
Gross profit: 2987000000
Operating income: 1076000000
Net income: 726000000
Capital expenditures: 124000000
Operating cash flow: 600000000
Depreciation & amortization: 148000000
Net tangible assets: -4753000000
Owner earnings: 750000000
Return on net tangible assets (%): -15.779507679360405
Capex to operating income (%): 11.524163568773234
Buffett classification: The Great
Stock price: 90.88
P/E ratio: 25.04173708429752
Shares outstanding: 800189310
Book value: 733000000
P/B ratio: 99.21037447858116
Market cap (USD): 72721204492.8
Debt to equity: 11.281036834924965
Current ratio: 0.8473983384346305
Quick ratio: 0.5376767235096924
Effective tax rate (%): 23.819517313746065
Interest coverage ratio: 16.303030303030305
COGS to revenue (%): 39.177356953777235
SG&A to revenue (%): 38.64793321115862
Free cash flow (dilution-adjusted): 453000000
Buyback yield (%): 0.39053258534533536
Retained earnings: 26413000000
Inventory turnover: 0.9054117647058824
Receivables turnover: 2.8469565217391306
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.995299407316574
FCF margin (%): 9.224190592547343
Rule of 40 score: 9.224190592547343
Financial ratios for CL — quarterly report dated 2025-06-30
Total revenue: 5110000000
Gross profit: 3069000000
Operating income: 1080000000
Net income: 773000000
Capital expenditures: 108000000
Operating cash flow: 884000000
Depreciation & amortization: 151000000
Net tangible assets: -4898000000
Owner earnings: 816000000
Return on net tangible assets (%): -16.6598611678236
Capex to operating income (%): 10
Buffett classification: The Great
Stock price: 88.66
P/E ratio: 47.32807486631087
Shares outstanding: 800189310
Book value: 1052000000
P/B ratio: 67.43800781806083
Market cap (USD): 70944784224.59999
Debt to equity: 8.32509505703422
Current ratio: 0.8850184501845019
Quick ratio: 0.5721033210332104
Effective tax rate (%): 23.23733862959285
Interest coverage ratio: 15.211267605633802
COGS to revenue (%): 39.9412915851272
SG&A to revenue (%): 38.41487279843444
Free cash flow (dilution-adjusted): 744000000
Buyback yield (%): 0.3270148785928006
Retained earnings: 26735000000
Inventory turnover: 0.9627358490566038
Receivables turnover: 2.8821206993795827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.098176718092567
FCF margin (%): 14.559686888454012
Revenue growth (%): 4.052127876196294
Rule of 40 score: 18.611814764650305
Financial ratios for CL — quarterly report dated 2025-09-30
Total revenue: 5131000000
Gross profit: 3049000000
Operating income: 1059000000
Net income: 766000000
Capital expenditures: 155000000
Operating cash flow: 1261000000
Depreciation & amortization: 158000000
Net tangible assets: -4735000000
Owner earnings: 769000000
Return on net tangible assets (%): -16.24076029567054
Capex to operating income (%): 14.636449480642117
Buffett classification: The Great
Stock price: 78.44
P/E ratio: 27.711633322913908
Shares outstanding: 800189310
Book value: 1238000000
P/B ratio: 50.700201515670436
Market cap (USD): 62766849476.4
Debt to equity: 6.80048465266559
Current ratio: 0.9296490147783252
Quick ratio: 0.6049876847290641
Effective tax rate (%): 22.782258064516128
Interest coverage ratio: 15.805970149253731
COGS to revenue (%): 40.576885597349445
SG&A to revenue (%): 38.41356460728903
Free cash flow (dilution-adjusted): 1034000000
Buyback yield (%): 0.45884093658115893
Retained earnings: 27051000000
Inventory turnover: 0.9871977240398293
Receivables turnover: 2.8395130049806308
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.6124171734592
FCF margin (%): 20.152017150652892
Revenue growth (%): 0.410958904109589
Rule of 40 score: 20.56297605476248
Financial ratios for CL — quarterly report dated 2025-12-31
Total revenue: 5230000000
Gross profit: 3146000000
Operating income: 1019000000
Net income: -5000000
Capital expenditures: 177000000
Operating cash flow: 1453000000
Depreciation & amortization: 173000000
Net tangible assets: -4604000000
Owner earnings: -9000000
Capex to operating income (%): 17.369970559371932
Buffett classification: The Great
Stock price: 78.05
P/E ratio: 27.634856480309733
Shares outstanding: 800189310
Book value: 365000000
P/B ratio: 171.10897437123288
Market cap (USD): 62454775645.5
Debt to equity: 23.435616438356163
Current ratio: 0.8330658105939005
Quick ratio: 0.5365533343061433
Effective tax rate (%): 104.62962962962963
Interest coverage ratio: 15.921875
COGS to revenue (%): 39.847036328871894
SG&A to revenue (%): 39.5793499043977
Free cash flow (dilution-adjusted): 1248000000
Buyback yield (%): 0.6500703842160919
Retained earnings: 26595000000
Inventory turnover: 1.0255905511811023
Receivables turnover: 3.1223880597014926
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.752347789384826
FCF margin (%): 23.862332695984705
Revenue growth (%): 1.929448450594426
Rule of 40 score: 25.79178114657913
Financial ratios for CL — annual report dated 2025-12-31
Total revenue: 20382000000
Gross profit: 12251000000
Operating income: 4233000000
Net income: 2261000000
Capital expenditures: 564000000
Operating cash flow: 4198000000
Depreciation & amortization: 630000000
Net tangible assets: -4604000000
Owner earnings: 2327000000
Return on net tangible assets (%): -50.54300608166812
Capex to operating income (%): 13.32388377037562
Buffett classification: The Great
Stock price: 78.05
P/E ratio: 27.62263407585139
Shares outstanding: 800189310
Book value: 365000000
P/B ratio: 171.10897437123288
Market cap (USD): 62454775645.5
Debt to equity: 23.435616438356163
Current ratio: 0.8330658105939005
Quick ratio: 0.5365533343061433
Effective tax rate (%): 26.08695652173913
Interest coverage ratio: 15.853932584269662
COGS to revenue (%): 39.893042880973404
SG&A to revenue (%): 38.77440879207143
Free cash flow (dilution-adjusted): 3479000000
Buyback yield (%): 1.9374018839937712
Retained earnings: 26595000000
Inventory turnover: 4.001476377952756
Receivables turnover: 12.168358208955224
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.66603355492245
FCF margin (%): 17.068982435482287
Revenue growth (%): 1.3979404009750758
Rule of 40 score: 18.466922836457364
Financial ratios for CYH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.31
Shares outstanding: 140916712
Market cap (USD): 1875601436.72
Buyback yield (%): 0.2665811564286207
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYH — annual report dated 2022-12-31
Total revenue: 12211000000
Gross profit: 10236000000
Operating income: 719000000
Net income: 179000000
Capital expenditures: 377000000
Operating cash flow: 300000000
Depreciation & amortization: 534000000
Net tangible assets: -5533000000
Owner earnings: 336000000
Return on net tangible assets (%): -6.072654979215615
Capex to operating income (%): 52.43393602225312
Buffett classification: The Good
Stock price: 4.32
P/E ratio: 3.400894948826816
Shares outstanding: 140916712
Book value: -734000000
Market cap (USD): 608760195.84
Debt to equity: -16.877384196185286
Current ratio: 1.4098810612991766
Quick ratio: 1.2483989021043
Effective tax rate (%): 48.71060171919771
Interest coverage ratio: 0.836046511627907
COGS to revenue (%): 16.173941528130374
SG&A to revenue (%): 46.24518876422897
Free cash flow (dilution-adjusted): -135000000
Buyback yield (%): 1.3141463674314595
Retained earnings: -3431000000
Inventory turnover: 5.594900849858357
Receivables turnover: 5.362758014931928
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.759833373387807
FCF margin (%): -1.105560560150684
Rule of 40 score: -1.105560560150684
Financial ratios for CYH — annual report dated 2023-12-31
Total revenue: 12490000000
Gross profit: 10497000000
Operating income: 870000000
Net income: 16000000
Capital expenditures: 439000000
Operating cash flow: 210000000
Depreciation & amortization: 505000000
Net tangible assets: -5350000000
Owner earnings: 82000000
Return on net tangible assets (%): -1.5327102803738317
Capex to operating income (%): 50.45977011494253
Buffett classification: The Good
Stock price: 3.13
P/E ratio: 27.566831784999998
Shares outstanding: 140916712
Book value: -824000000
Market cap (USD): 441069308.56
Debt to equity: -14.774271844660195
Current ratio: 1.4976657329598506
Quick ratio: 1.3445378151260505
Effective tax rate (%): 92.27053140096618
Interest coverage ratio: 1.0456730769230769
COGS to revenue (%): 15.956765412329865
SG&A to revenue (%): 45.90872698158527
Free cash flow (dilution-adjusted): -279000000
Buyback yield (%): 0.9068869500485472
Retained earnings: -3564000000
Inventory turnover: 6.076219512195122
Receivables turnover: 5.014050582095544
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.06570291561764
FCF margin (%): -2.233787029623699
Revenue growth (%): 2.2848251576447467
Rule of 40 score: 0.05103812802104768
Financial ratios for CYH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.07
Shares outstanding: 140916712
Market cap (USD): 855364441.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYH — annual report dated 2024-12-31
Total revenue: 12634000000
Gross profit: 10688000000
Operating income: 843000000
Net income: -362000000
Capital expenditures: 355000000
Operating cash flow: 480000000
Depreciation & amortization: 486000000
Net tangible assets: -5703000000
Owner earnings: -231000000
Capex to operating income (%): 42.11150652431791
Buffett classification: The Good
Stock price: 2.99
Shares outstanding: 140916712
Book value: -1317000000
Market cap (USD): 421340968.88000005
Debt to equity: -9.189066059225512
Current ratio: 1.4076759061833688
Quick ratio: 1.2665245202558635
Interest coverage ratio: 0.9768250289687138
COGS to revenue (%): 15.402881114453063
SG&A to revenue (%): 45.25091024220358
Free cash flow (dilution-adjusted): 103000000
Buyback yield (%): 0.23733747104113315
Retained earnings: -4080000000
Inventory turnover: 5.879154078549849
Receivables turnover: 5.009516256938937
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.1995900589290285
FCF margin (%): 0.8152604084217191
Revenue growth (%): 1.1529223378702964
Rule of 40 score: 1.9681827462920154
Financial ratios for CYH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.99
Shares outstanding: 140916712
Market cap (USD): 421340968.88000005
Buyback yield (%): 0.23733747104113315
Capitalized R&D asset: 0
Rule of 40 score: 0